No longer accepting applications (expired, filled, etc.)
MindMed
Executive Director, Expanded Access and Phase 4 Clinical Strategy
The Executive Director, Expanded Access & Phase 4 Clinical Strategy is responsible for the end-to-end strategy, design, and execution of Expanded Access Programs and Phase 4 studies. This role involves strategic leadership and hands-on execution to ensure programs are scientifically sound, operationally feasible, regulator-ready, and aligned with integrated asset strategy including lifecycle management and real-world evidence generation.
Key Responsibilities
- • Own and lead the global strategy for Expanded Access Programs and Phase 4 development, aligned with asset lifecycle objectives, patient access goals, and regulatory expectations
- • Partner with the CMO, Clinical Development, Medical Affairs, Regulatory Affairs, Commercial, Asset Strategy Lead and Program Leadership to ensure EAP and Phase 4 activities are fully integrated into the overall asset strategy and Target Product Profile (TPP)
- • Serve as the clinical development lead for governance discussions related to post-approval and access strategies, clearly articulating risks, trade-offs, and recommendations
- • Design and implement Expanded Access Programs, including protocol development, eligibility criteria, safety oversight, and operational execution
- • Lead cross-functional planning to ensure EAPs are compliant, scalable, ethically sound, and aligned with regulatory guidance
- • Provide clinical leadership for benefit–risk assessment, safety monitoring, and ongoing program evaluation
- • Define Phase 4 objectives, including real-world evidence generation, long-term safety, effectiveness, and differentiation in the treatment landscape
- • Lead the design, planning, and execution of Phase 4 studies, including protocol development, data collection strategies, and interpretation of outcomes
- • Ensure Phase 4 programs address regulatory commitments, payer needs, and scientific gaps
- • Lead preparation and review of clinical content for regulatory submissions and interactions as applicable
- • Act as a clinical subject matter expert in interactions with U.S. and ex-U.S. health authorities related to Expanded Access and Phase 4 activities
- • Oversee clinical input into Investigator Brochures, clinical study reports, in collaboration with Regulatory Affairs
- • Work collaboratively with Clinical Operations, Data Management, Biostatistics, Pharmacovigilance, and Project Management to ensure high-quality execution
- • Establish and maintain relationships with key investigators, advisors, and external experts to support EAP and Phase 4 objectives
- • Provide clinical leadership within matrix teams, modeling accountability, collaboration, and scientific rigor
Required
- • Doctoral degree required (MD, PhD, PharmD, PsyD)
- • 10+ years of clinical development experience in the pharmaceutical or biotechnology industry
- • Demonstrated experience leading late-stage, post-approval, Expanded Access, and/or Phase 4 programs
- • Deep understanding of clinical development, regulatory pathways, and lifecycle management
- • Proven ability to translate strategy into execution in resource-constrained environments
- • Track record of effective cross-functional leadership and external stakeholder engagement
- • Ability to operate with diplomacy, influence without authority, and command credibility with senior leaders and external experts
- • Excellent verbal and written communication skills
- • Self-motivated, adaptable, and comfortable balancing strategic thinking with hands-on contribution
Preferred
- • CNS development experience (psychiatry or neurology) strongly preferred
- • Experience in small-molecule development preferred
Benefits & Perks
- • 100% paid health benefits including Medical, Dental and Vision for you and your dependents
- • 401(k) program with company match and immediate vesting
- • Flexible time off
- • Generous parental leave and some fun fringe perks!
Company Overview
Industry: Healthcare Technology
Company Size: 500-1,000 employees
Founded: 2015
Headquarters: San Francisco, CA
Company Links
Key Contacts
Contact information not available
About the Company
Leading healthcare technology company focused on improving patient outcomes through innovative digital solutions. We're transforming the way healthcare is delivered with cutting-edge technology and data-driven insights. Our platform serves over 10,000 healthcare professionals and has processed millions of patient interactions.
Recent News & Updates
Series B
Raised $50M Series B funding - Jan 2024
Award
Named "Best Healthcare Startup" by TechCrunch - Dec 2023
Growth
Expanded to 5 new states - Nov 2023
MindMed is a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders. Our mission is to be the global leader in the development and delivery of treatments that unlock new opportunities to improve patient outcomes. We are developing a pipeline of innovative product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways that play key roles in brain health.
Founded in 2019, we are continuously expanding our presence and global footprint. We are constantly searching for high-impact individuals in various clinical, technical and business operations domains to strengthen our team of patient-centric, intelligent individuals.
The Executive Director, Expanded Access & Phase 4 Clinical Strategy will be accountable for the end‑to‑end strategy, design, and execution of Expanded Access Programs and Phase 4 studies across MindMed's portfolio. This leader will ensure programs are scientifically sound, operationally feasible, regulator‑ready, and aligned with the integrated asset strategy, including lifecycle management, real‑world evidence generation, and post‑approval commitments.
This role requires both strategic leadership and hands‑on execution, with the ability to operate effectively in a lean, fast‑moving organization.
Responsibilities
Strategic Leadership
Education & Experience
Employees in this role may be entitled to additional compensation, including bonus and equity. Benefits information is listed on our Jobs Page. The Company provides competitive benefits to employees including:
Founded in 2019, we are continuously expanding our presence and global footprint. We are constantly searching for high-impact individuals in various clinical, technical and business operations domains to strengthen our team of patient-centric, intelligent individuals.
The Executive Director, Expanded Access & Phase 4 Clinical Strategy will be accountable for the end‑to‑end strategy, design, and execution of Expanded Access Programs and Phase 4 studies across MindMed's portfolio. This leader will ensure programs are scientifically sound, operationally feasible, regulator‑ready, and aligned with the integrated asset strategy, including lifecycle management, real‑world evidence generation, and post‑approval commitments.
This role requires both strategic leadership and hands‑on execution, with the ability to operate effectively in a lean, fast‑moving organization.
Responsibilities
Strategic Leadership
- Own and lead the global strategy for Expanded Access Programs and Phase 4 development, aligned with asset lifecycle objectives, patient access goals, and regulatory expectations
- Partner with the CMO, Clinical Development, Medical Affairs, Regulatory Affairs, Commercial, Asset Strategy Lead and Program Leadership to ensure EAP and Phase 4 activities are fully integrated into the overall asset strategy and Target Product Profile (TPP)
- Serve as the clinical development lead for governance discussions related to post‑approval and access strategies, clearly articulating risks, trade‑offs, and recommendations
- Design and implement Expanded Access Programs, including protocol development, eligibility criteria, safety oversight, and operational execution
- Lead cross‑functional planning to ensure EAPs are compliant, scalable, ethically sound, and aligned with regulatory guidance
- Provide clinical leadership for benefit–risk assessment, safety monitoring, and ongoing program evaluation
- Define Phase 4 objectives, including real‑world evidence generation, long‑term safety, effectiveness, and differentiation in the treatment landscape
- Lead the design, planning, and execution of Phase 4 studies, including protocol development, data collection strategies, and interpretation of outcomes
- Ensure Phase 4 programs address regulatory commitments, payer needs, and scientific gaps
- Lead preparation and review of clinical content for regulatory submissions and interactions as applicable
- Act as a clinical subject matter expert in interactions with U.S. and ex‑U.S. health authorities related to Expanded Access and Phase 4 activities
- Oversee clinical input into Investigator Brochures, clinical study reports, in collaboration with Regulatory Affairs
- Work collaboratively with Clinical Operations, Data Management, Biostatistics, Pharmacovigilance, and Project Management to ensure high‑quality execution
- Establish and maintain relationships with key investigators, advisors, and external experts to support EAP and Phase 4 objectives
- Provide clinical leadership within matrix teams, modeling accountability, collaboration, and scientific rigor
Education & Experience
- Doctoral degree required (MD, PhD, PharmD, PsyD)
- 10+ years of clinical development experience in the pharmaceutical or biotechnology industry
- Demonstrated experience leading late‑stage, post‑approval, Expanded Access, and/or Phase 4 programs
- CNS development experience (psychiatry or neurology) strongly preferred
- Experience in small‑molecule development preferred
- Deep understanding of clinical development, regulatory pathways, and lifecycle management
- Proven ability to translate strategy into execution in resource‑constrained environments
- Track record of effective cross‑functional leadership and external stakeholder engagement
- Ability to operate with diplomacy, influence without authority, and command credibility with senior leaders and external experts
- Excellent verbal and written communication skills
- Self‑motivated, adaptable, and comfortable balancing strategic thinking with hands‑on contribution
- Comfortable rolling up sleeves while maintaining a strategic perspective
- Energized by innovation in clinical research and patient‑centric access models
- Thrives in a fast‑paced, evolving environment with high accountability
- Acts as a role model for scientific excellence, integrity, and collaboration
Employees in this role may be entitled to additional compensation, including bonus and equity. Benefits information is listed on our Jobs Page. The Company provides competitive benefits to employees including:
- 100% paid health benefits including Medical, Dental and Vision for you and your dependents
- 401(k) program with company match and immediate vesting
- Flexible time off
- Generous parental leave and some fun fringe perks!
Keep track of your job search
Save personal notes for each job to track your thoughts, application status, and follow-ups.
Try for freeUpload your resume
Sign up to upload your resume and get AI-powered customization for job applications.
Sign up freePractice your interview
Get AI-powered mock interviews tailored to this Executive Director, Expanded Access and Phase 4 Clinical Strategy role. Upload your resume and practice with real-time voice feedback.
Sign up to practice